OE33 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1122-YF1887
Target Cell Organism: Human
Target Cell Alternative Name: JROECL33
Target Cell Name: OE33
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide OE33-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
OE33
Target Cell Organism
Human
Target Cell Background
The cell line OE33, also known as JROECL33, was established from the adenocarcinoma of the lower oesophagus (Barrett's metaplasia) of a 73 year old female patient. The tumour was identified as pathological stage IIA (UICC) and showed poor differentiation.
Target Cell Alternative Name
JROECL33
Related Diseases
Esophageal Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
OE33-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry